arrow
S

Steven A. Narod

womens college research and innovation institute
H指数:128
被引数:8.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Germline ATRIP variants and the risk of ovarian cancer

生殖系ATRIP变异与卵巢癌风险

2026-05-120
OAAI
The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in BRCA1

BRCA1致病性变异携带者中,根据突变类型和位置划分的乳腺癌风险

2025-12-150
OAAI
Endometriosis in Carriers of a Pathogenic Variant in BRCA1 or BRCA2: A Descriptive Analysis of a Large Multicentral BRCA Carrier Cohort

BRCA1或BRCA2致病性变异携带者中的子宫内膜异位症:一项大型多中心BRCA携带者队列的描述性分析

2025-12-010
OAAI
Bilateral oophorectomy and the probability of amnestic mild cognitive impairment among carriers of a pathogenic variant in BRCA1 or BRCA2

双侧卵巢切除术与携带BRCA1或BRCA2致病性变异者患遗忘型轻度认知障碍的概率

2025-05-100
PRE
Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variant

产次、母乳喂养与携带BRCA1致病性变异女性早期乳腺癌的风险

2025-05-020
PRE
The incidence of pancreatic cancer in women with a BRCA1 or BRCA2 mutation

BRCA1或BRCA2突变女性的胰腺癌发病率

CANCER
IF5.1
2024-11-290
PRE
ASO Visual Abstract: The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT Study
2024-07-150
OA
Incidence of peritoneal cancer after oophorectomy among BRCA1 and BRCA2 mutation carriers

BRCA1和BRCA2突变携带者卵巢切除术后腹膜癌的发生率

2024-06-271
PRE
The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT Study

保乳手术后导管原位癌患者放射治疗决策的7基因生物签名的临床效用: dcision rt的最新分析®预测研究

2024-06-258
OAAI
Blood Iodine as a Potential Marker of the Risk of Cancer in BRCA1 Carriers

血碘作为BRCA1携带者癌症风险的潜在标志物

2024-06-062
OAAI
Zinc and Its Antioxidant Properties: The Potential Use of Blood Zinc Levels as a Marker of Cancer Risk in BRCA1 Mutation Carriers

锌及其抗氧化特性: 血液锌水平作为BRCA1突变携带者癌症风险标志物的潜在用途

2024-05-166
OAAI
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Pathogenic Variants in BRCA1 and BRCA2
2024-05-020
PRE